WebApr 11, 2024 · In a statement, the company’s CEO, Chris Viehbacher, announced that the new head of Business Development will focus on expanding Biogen’s strategy, primarily through external collaborations. Keeney’s appointment is the latest of a spate of personnel changes made by Viehbacher in a bid to lead Biogen past the challenges characterized … WebApr 10, 2024 · MS is Still Biogen’s Top Earner. During the investor call, Viehbacher said the MS franchise still supports most of Biogen’s revenue. In 2024, Biogen’s MS business earned $5.43 billion dollars, accounting for nearly 68% of the company’s full-year revenue. Still, at constant currencies, MS sales dropped 9% from the year prior due to ...
Biogen
Web1 day ago · Biogen is cutting its workforce again after laying off 885 people last year. ... the MS franchise still supports most of our revenue in the business," new CEO Christopher … WebApr 10, 2024 · MS is Still Biogen’s Top Earner. During the investor call, Viehbacher said the MS franchise still supports most of Biogen’s revenue. In 2024, Biogen’s MS business … citizen holdings llc
Biogen Announces New CEO Christopher Viehbacher – NBC Boston
WebNov 10, 2024 · Biogen Inc. has finally announced a new CEO, six months after Michel Vounatsos said he would be stepping down. Christopher Viehbacher, a longtime … WebMay 3, 2024 · The company plans to “substantially” eliminate the commercial team supporting Aduhelm, which has recorded paltry sales. Biogen is searching for a new CEO along with additional ways to cut costs after another quarter of paltry sales for its closely watched Alzheimer's disease drug. Once considered a blockbuster-in-waiting, Aduhelm, … WebBiogen Searches for New CEO in Wake of Struggles With Alzheimer’s Drug Launch. Less than a year after a shocking Food and Drug Administration approval that sent its share price up nearly 40% in ... citizen holdings holdings